MRI assessment of the postprandial gastrointestinal motility and peptide response in healthy humans by Khalaf, Asseel et al.
  
MRI assessment of the postprandial gastrointestinal motility and peptide 
response in healthy humans 
RUNNING HEAD: GI motility response to a meal by MRI 
Asseel Khalaf1,2, Caroline L. Hoad2,3, Alex Menys4, Adam Nowak2, Stuart A. Taylor4, 
Stephen Paparo1,2, Melanie Lingaya2, Yirga Falcone2, Gulzar Singh2, Robin C. 
Spiller1,2, Penny A. Gowland3, Luca Marciani1,2 and Gordon W. Moran1,2 
 
1Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham 
UK 
2NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases at Nottingham 
University Hospitals NHS Trust and the University of Nottingham 
3Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of 
Nottingham, Nottingham UK 
4Centre for Medical Imaging, Division of Medicine, UCL UK 
 
Corresponding author: 
Dr Gordon W. Moran 
Clinical Associate Professor of Gastroenterology 
NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases at Nottingham 
University Hospitals NHS Trust and the University of Nottingham 
Nottingham NG7 2UH, U.K. 
E-mail: gordon.moran@nottingham.ac.uk   
 
KEY WORDS: Gastrointestinal motility; gut peptides; MRI; satiety; bowel 
  
 
 
KEY MESSAGES: 
 The clinical relevance of measuring intestinal motility using MRI has been 
recently shown. However most investigative MRI paradigms are undertaken in 
the fasting state using bowel preparation. Here we develop pan-intestinal 
motility assessment in a single session using MRI in a fed and physiological 
state and compare imaging findings to postprandial GI peptide responses and 
symptoms in healthy volunteers. 
 The test meal challenge was effective in inducing a change in multiple 
physiological quantified end-points and in monitoring markers of GI motility in 
a single MRI study session which was acceptable to the subjects. 
 Mapping out post-prandial physiological changes in disease groups will allow 
us to better understand patient symptoms and perhaps identify GI peptides as 
possible biomarkers of dysmotility and patient symptoms. This work will serve 
as a platform to enhance our diagnostic capabilities in relevant disease groups 
such as Crohn’s. 
   
 
Abstract 
Background: Feeding triggers inter-related gastrointestinal (GI) motor, peptide and 
appetite responses. These are rarely studied together due to methodological 
limitations. Recent MRI advances allow pan-intestinal, non-invasive assessment of 
motility in the undisturbed gut. 
This study aimed to develop a methodology to assess pan-intestinal motility and transit 
in a single session using MRI and compare imaging findings to GI peptide responses 
to a test meal and symptoms in a healthy volunteer cohort.  
Methods: Fifteen healthy volunteers (29.3±2.7years and BMI 20.1±1.2Kg/m2) 
underwent baseline and postprandial MRI scans, symptom questionnaires and blood 
sampling (for subsequent GI peptide analysis, Glucagon-like peptide-1 (GLP-1), 
Polypeptide YY (PYY), Cholecystokinin (CCK)) at intervals for 270min following a 400g 
soup meal (204kcal, Heinz, UK). Gastric volume, gall bladder volume, small bowel 
water content, small bowel motility and whole gut transit were measured from the MRI 
scans. 
Key Results: (mean±SEM) Small bowel motility index increased from fasting 39±3 
arbitrary units (a.u.) to a maximum of 87±7a.u. immediately after feeding. PYY 
increased from fasting 98±10pg/ml to 149±14pg/ml at 30min and GLP-1 from fasting 
15±3µg/ml to 22±4µg/ml. CCK increased from fasting 0.40±0.06pmol/ml to 
0.94±0.1pmol/ml. Gastric volumes declined with a T1/2 of 46±5min and the gallbladder 
contracted from a fasting volume of 19±2ml to 12±2ml. Small bowel water content 
increased from 39±2ml to 51±2ml postprandial. Fullness VAS score increased from 
9±5mm to 41±6mm at 30min postprandial.  
Conclusions and Inferences: The test meal challenge was effective in inducing a 
   
change in MRI motility end-points which will improve understanding of the 
pathophysiological postprandial GI response. 
   
Introduction  
The clinical relevance of measuring intestinal motility has been recently shown through 
its correlation to intestinal inflammation in Crohn’s disease 1, 2.  
MRI methodology has recently come to the fore offering repeatable means to measure 
global and segmental motility3. Further, MR does not expose the subject to ionising 
radiation, permitting serial scanning 4-6 which is commonly indicated in chronic 
intestinal disorders.  
Abdominal pain represents a predominant symptom both in functional and organic 
intestinal diseases and commonly occurs in the post-prandial state rather than after a 
prolonged fast. Feeding triggers a range of gastrointestinal (GI) responses such as 
motility and secretion of fluid and hormones. Postprandial GI motility is stimulated by 
luminal distention and is modulated by luminal nutrients. Enteroendocrine cells react 
to the luminal contents by releasing a variety of gastrointestinal peptides like 
Cholecystokinin (CCK), Peptide YY (PYY) and Glucagon-like peptide 1 (GLP-1) 7. CCK 
delays gastric emptying and stimulates gall bladder contraction 8, PYY slows meal 
transit through a delay in gastric emptying and increasing the GI transit time (known 
as ileal brake) 9, while GLP-1 delays gastric emptying 10 and decreases small bowel 
motility separately 11, 12. 
It thus comes as rather a major diagnostic limitation that most investigative MR 
paradigms are undertaken in the fasting patient and not in the physiological state with 
an abnormally distended bowel with contrast agent. Advances in the availability of MRI 
scanners, increases in the speed of acquisition and growing acceptance of this method 
for the investigation gastrointestinal disease has driven its role in the GI physiology. A 
number of techniques to assess fasting motility in ta fasted and prepared during an MR 
enterography (MRE) are now available 13 enabling rapid, reproducible and sensitive 
   
assessment of global and segmental motility to complement morphological changes 
seen through structural imaging 14, 15.   
In this study we aim to develop a methodology to assess pan-intestinal motility 
assessment in a single session using MRI in a fed and physiological state and to 
compare imaging findings to postprandial GI peptide responses and key patient 
symptoms in a healthy volunteer’s cohort. This work will serve as a platform to enhance 
our understanding of GI physiology and diagnostic capabilities in relevant disease 
groups.  
 
 Materials and methods 
Subjects  
This study was approved by the local Ethics Committee of the University of Nottingham 
(H19062014). This study is registered on clinical trials.gov with identifier 
NCT02717117.  All participants gave informed written consent.   
Healthy volunteers (median age 26 (range 19-50) years, BMI mean 20±1 kg/m2) were 
recruited from the local campus population. Participants with a history of inflammatory 
bowel disease, smokers 16, a history of bowel resections or any gastrointestinal 
surgery, history of pancreatic insufficiency, thyroid disease, diabetes, protein-pump 
inhibitor usage or any medication that affects gastric emptying or small bowel transit 
and any potential participants scoring very highly on the depression scale 
questionnaire were excluded. Standard MRI exclusion criteria were applied. 
Test meal 
The test meal consisted of: cream of chicken soup (400g) (or mushroom for 
vegetarians) (Heinz, Wigan, UK), chosen respectively by 6 and 9 participants. The 
   
nutrient content of this meal/100g was: energy (kcal) 51, protein 1.5 g (1.5%), 
carbohydrate 4.7 g (4.5%), fat 2.9 g (2.9%). This meal has been previously shown to 
reliably induce a GI peptide response17, 18.  
Study design 
This study was open label. MRI marker capsules were used to measure whole gut 
transit time19. Participants were given 5 MRI marker capsules (20 mm x 7 mm) filled 
with 0.4mL 15M Gadoteric acid, an MRI contrast agent, to take home.  They were 
instructed to swallow these 24 h before attending the unit for their study day and 
undergoing the baseline MRI scans as previously described19. They were asked to fill 
in a questionnaire to ensure adherence to the study day restrictions. 
The subjects were asked to fast from 2000 h the previous evening and to avoid alcohol, 
caffeine, strenuous exercise and any medication that could affect gut function for 18 h 
before the experiment (S1).  
On the day of the scan, Participants attended the 1.5T Philips Achieva MRI scanner 
(Philips Healthcare, Best, the Netherlands) at the Sir Peter Mansfield Imaging Centre 
(SPMIC) at the University Park Campus, University of Nottingham. Participants were 
cannulated at arrival (0800) and underwent a baseline fasting scan at 0900 hours 
(defined at t = -20 min time point), together with a fasting baseline blood sample. The 
60 minute interval between cannulation and acquisition of baseline measurements was 
introduced to allow the subjects to normalise to a baseline calm physiological state. At 
0925 hours, they were asked to consume all their test meal in a quiet lounge next to 
the scanner within a maximum time of 20 min so that at 0945 hours the subjects 
underwent a first immediate postprandial scan (defined as t = 0 min).  
This was followed with data collection (MRI, questionnaire data and 10 ml blood 
   
samples) time points every 15 min for the first 60 min and then every 30 min up to 270 
min. Blood samples were collected by a research nurse. The first 2 mL of each sample 
was discarded to avoid contamination with the saline used to maintain patency. Blood 
was collected into vacutainer tubes containing 0.325 mL of aprotinin, (Trasylol, Bayer) 
(Dorset, England).  
At each time point, the MRI procedures took approximately 15 minutes, including 
subject positioning on the scanner bed, setup of the MRI scans and data collection. 
For the first 60 minutes the subjects were kept inside the scanner. After this the 
subjects were kept sitting upright in a quiet lounge next to the scanner for the rest of 
the study day except for the subsequent MRI acquisitions. At each time point, they 
filled a 100mm Visual analogue scale (VAS) symptoms questionnaire scoring their 
feeling of fullness, bloating, distension, abdominal pain/discomfort and nausea17. The 
VAS anchors are from ‘not’ to ‘extremely’. At the end of the 270 min healthy volunteers 
were allowed to leave.  
Magnetic Resonance Imaging 
MRI scanning was carried out supine. Participants were scanned using a range of 
sequences. At each time point scans were acquired to assess gastric volume 20, gall 
bladder volume 21, small bowel water content 22 and small bowel motility 15.  In addition 
at baseline the position of the MRI marker capsules were determined to measure whole 
gut transit time19. 
Gastric emptying was assessed using a balanced gradient echo sequence (bTFE) 
acquiring 50 contiguous axial slices with reconstructed in-plane resolution 2.0x 1.77 
mm2, slice thickness 5 mm and 0 mm slice gap, echo time (TE) =1.5 ms, repetition 
time (TR) =3.0ms, flip angle 80º, SENSE 2.0 within one breath hold of ~16 s. This 
   
imaging sequence yields good contrast between the stomach contents and other 
abdominal organs. Samples containing mobile water appear brighter than viscous 
samples with reduced water content and mobility.  
The content of apparent freely mobile water in the small bowel was assessed as 
previously described22 using a single-shot fast spin echo sequence acquiring 24 
contiguous coronal slices with reconstructed in-plane resolution 0.78 x 0.78mm2, slice 
thickness 7mm and slice gap 0mm, TE =320 ms, TR =8000 ms, SPIR fat saturation 
within one breath hold of 24 s. This sequence yields high-intensity signals from areas 
with freely mobile fluid and dark signals from poorly mobile or bound water and all other 
body tissues.  
Small bowel motility was assessed using a single slice cine-MRI acquisition set at six 
contiguous parallel coronal planes through the small bowel. Data was acquired using 
a balanced gradient echo sequence (bTFE) with reconstructed in-plane resolution 1.49 
x 1.7 mm2, echo time (TE) =1.52 ms, repetition time (TR) =3.0 ms, flip angle 80º, 
SENSE 2.0 at a repetition time of 1 image per second for a duration of 1 minute for 
each plane with gentle free breathing throughout the acquisition. 
Whole gut transit was assessed using two different Coronal 3D T1 weighted turbo field 
echo (TFE) sequences. Each comprised two separate stacks with a 30 mm overlap, 
acquired on two separate breath holds.  Firstly a T1 weighted 3D TFE sequence with 
SPAIR fat saturation. Sequence parameters for each station were as follows: TE = 1.9 
ms, TR  = 4.0 ms, FA = 10 , FOV = 250 x 398 x 160 mm3.  Acquired resolution 2.3 x 
2.3 x 5 mm3, reconstructed to 1.4 x 1.4 x 2.5 mm3, with a 288 x 288 reconstructed 
matrix.  64 slices were acquired with a half-scan factor of 0.7 in the phase direction 
and 0.85 in the slice direction in a 23 sec breath hold.  The second sequence, another 
T1-weighted 3D TFE sequence with a 2-echo readout and mDIXON reconstruction of 
   
the water only images 23 was acquired with increased resolution using SENSE and 36 
maximum intensity projection (MIP) images were generated from this data to create a 
3D view of the colon to aid in defining the position of the capsules.  Imaging parameters 
at each station were as follows:  TE1/TE2 = 1.4/2.5 ms, TR  = 3.8 ms, FA = 10 , FOV 
= 250 x 371 x 200 mm3.  Acquired resolution 1.8 x 1.8 x 3.6 mm3, reconstructed to 1.0 
x 1.0 x 1.8 mm3, with a 384 x 384 reconstructed matrix.  111 slices were acquired with 
a SENSE factor of 2.0 in the phase direction in a 22 s breath holds. 
Gall bladder volume was measured pre- and post-prandial, at every acquisition time 
point up to 60 min postprandially21. This was carried out using the same images as for 
the gastric volumes as previously shown. 
Plasma collection and peptides assays analysis 
On the morning of the test, 0.325 ml of aprotinin was added to vacutainer tubes (BD-
361017, BD Diagnostics, Oxford) for collection for each time point aiming for a final 
volume of 6.5 ml. Fasting 10 ml blood sample was drawn and collected in the tubes. 
After the test meal, data were acquired every 15 min for the first 60 min and every 30 
min thereafter to 270 min. Twelve samples were taken totalling 120 ml. Samples were 
centrifuged at 3000 rpm for 10 min and stored on ice17. Plasma peptides (total GLP-1, 
total PYY) were analysed through enzyme-linked immunosorbent assay (ELISA) 
techniques (Millipore, UK) as previously shown17. The concentrations of serum CCK 
were measured by radioimmunoassay (RIA) (Euro Diagnostic Products, Sweden) as 
previously shown24.  
Data analysis 
Motility assessment 
All dynamic data was processed with Dual Registration of Abdominal Motion (DRAM) 
   
(Motilent, Ford, UK). DRAM first removes respiratory motion25 before applying the optic 
flow registration as previously described by Odille et al14 to correct local deformation 
caused by bowel wall motion and model intensity changes caused by luminal flow. 
Registration results were further analysed using a customised graphical user interface 
written in MATLAB (MathWorks, Natick, MA, USA).  
Published methods of assessing small bowel motility have been applied in Magnetic 
Resonance Enterography (MRE)14, 15.  MRE involves distending the bowel lumen with 
a large volume of luminal contrast medium, which stimulates wall movement and 
facilitates at the same time the registration process. The aim of our project was to 
measure motility in a physiological state after a nutrient meal rather than an artificially 
distended state. Since postprandial small bowel motility does not produce the same 
motion or appearance of the lumen as in MRE, a different approach to assessing the 
small bowel motility was required. The technique used in this study quantified the 
motility of the bowel using the pixel signal changes through the time series, within a 
defined region of interest (ROI) placed over the small bowel loops. The metric was 
calculated as follows: 
For each pixel in the registered dataset, a power spectrum of the intensity changes 
across the time series (smoothed using a running average of 5 pixels to reduce noise) 
was calculated and then summed across all frequencies. This metric was termed the 
total power, and reflected bowel motility, both in terms of segmental oscillations and 
bolus movement of contents, typically seen postprandially 26.  
Two independent observers (AK, CH) drew ROIs manually over all the loops of the 
small bowel in all the slices for each imaging datasets (Figure 1). From these ROIs the 
mean total power across all small bowel pixels was calculated.  A larger total power 
motility index represents higher small bowel motility. 
   
Small bowel water content (SBWC) 
SBWC was measured as previously validated22, using in house software written in IDL 
(Research Systems Inc. Boulder, Colorado, USA).  Briefly, this method assumed that 
any pixel with signal intensity above the calculated threshold in the heavily T2-weighted 
coronal images is filled with free water.  Structures such as blood vessels, bladder and 
gall bladder are manually excluded. 
Gall bladder and gastric volumes 
Gall bladder and gastric volumes were quantified using in house software written in 
IDL (Research Systems Inc. Boulder, Colorado, USA). This method uses a semi-
automatic previously validated thresholding-region growing technique to define the 
content of the stomach and gas within the stomach on each image slice20. For total 
gastric volume was calculated as the sum of the stomach contents and any gas.   
Postprandial gastric content volumes were fitted to a 5 parameter equation27 to model 
the emptying process and allow the calculation of the gastric half-emptying time (T1/2) 
Whole gut transit (WGT) 
Whole gut transit was assessed as previously described19. From the two sets of MRI 
images a transit score was calculated by sub-dividing the bowel into eight sections and 
each capsule was scored according to its position in the colon at 24 h. A weighting 
factor was calculated for each capsule depending on the difference of the capsule 
score from the median capsule score.   
Visual analogue scale (VAS) 
Symptoms regarding appetite, satiety and abdominal pain were scored at each time 
point using previously validated questionnaire17.   
Statistical analyses 
   
Due to the pilot nature of this study, it was not possible to power it but similar studies 
done by our group have used similar-sized cohorts17, 28, 29. The data are expressed as 
mean±standard error of the mean (SEM). Normality of the data was assessed using 
Shapiro–Wilk’s test. One-way analysis of variance (ANOVA) was used to assess the 
significance of differences. When the analysis of variance was significant, post hoc test 
assessments of the individual time points were performed using the Dunnett’s for 
parametric data or Dunn’s test for non-parametric data, to account for multiple 
comparisons. All statistical analyses were performed using GraphPad Prism 7.01 (La 
Jolla, USA). A p-value less than 0.05 was considered statistically significant.  
 
Results 
All fifteen healthy volunteers (9 female, 6 male, age 29.3±2.7 years and BMI 20.1±1.2 
Kg/m2) completed the study and tolerated the experimental procedures well without 
any adverse event.  
Gallbladder volumes 
The changes in gallbladder volumes with time are shown in supplementary material 2 
(S2). This demonstrated a moderate and significant postprandial decrease in the 
volume from 19±2ml (mean ± SEM) at baseline to 12±2ml immediately postprandial 
t=0 min (p≤0.0001). 
Gastric volumes 
The baseline gastric volumes showed small amount of resting gastric juices of 26±7ml. 
Gastric content volumes rose significantly upon feeding to 418±17ml at t=0 (p≤0.0001) 
after which the volume of the stomach declined and went back to baseline (37±7ml) at 
150min with an average time to empty half of the stomach contents (T1/2) of 46±5min 
   
(Fig 2). 
Small bowel motility 
From figure 3 it can be seen that the motility index increased significantly from fasting 
39±3 arbitrary units (a.u.) to a maximum of 87±7 a.u. immediately postprandial (t=0min) 
(p≤0.001) after feeding and then gradually decreased back to around baseline (44±4 
a.u.) in 90 minutes. Motility index rose slightly again at 120 min to 55±4 a.u. and 
decreased back again to 38±4 a.u. at 240 min.  
Small bowel water content 
The data in figure 4 shows a small amount of fasting (t= -20min) small bowel water 
content of 39±2ml. The test meal induced a significant change in small bowel water 
content. Immediately, after the all soup meal was ingested, this increases to a 
maximum of 51±2ml (p≤0.05) at 15 min. The volume decreased towards baseline 
(38±2ml) at 60 min after which a second peak at 180 min is clearly seen with a volume 
of 65±3ml. 
Whole gut transit (WGT) 
The median average weighted position score (WAPS) of the MRI capsules was 1.0 (0-
3.8). As described previously19, the WAPS at 24 hr was converted to WGT in hours, 
giving a median of 33 hr. 
Total GLP-1 
The meal induced significant postprandial changes in plasma measures of total GLP-
1 (p≤0.01). The mean GLP-1 data (Fig 5) from healthy volunteers showed a 
postprandial peak from fasting volume of 15±3µg/ml to 22±4µg/ml (t=0 min). The GLP-
   
1 levels dropped (12±3µg/ml) after 30 minutes and remained around baseline levels 
for the rest of the study day.  
Total PYY 
PYY (Fig 6) increased significantly (p≤0.001) from fasting 98±10pg/ml to 149±14pg/ml 
at 30min postprandially in healthy volunteers. PYY returned to baseline after 2 hours 
postprandially and later dropped even further to reach 71±13pg/ml at 270 min.  
CCK 
Plasma CCK levels (Fig 7) increased significantly (p≤0.01) from fasting 
0.40±0.06pmol/ml to 0.94±0.1pmol/ml at t=30min and then steadily decreased after 60 
min to reach baseline (0.4±0.01pmol/ml) for the rest of the study day.  
Symptom VAS data 
The meal induced a significant increase in fullness. VAS increased from 9±5 to 44±5 
at 0 min and 41±6 at 30 min postprandial (p<0.001). The feeling returned to baseline 
thereafter. Bloating, distention, pain and nausea did not change significantly. (Table1). 
 
Discussion 
The test meal challenge was effective in inducing a change in multiple physiological 
quantified end-points and in monitoring markers of GI motility in a single MRI study 
session which was acceptable to the subjects. To our knowledge this is the first study 
measuring gut motility in an undisturbed bowel after a nutrient meal without artificially 
distending the bowel.  
The physiological parameters measured in this study were in the expected range for a 
normal healthy cohort as we have shown repeatedly in our previous studies28-30.  
   
The test meal was ingested within a maximum of 20 min by the 15 subjects and hence 
acted as a food bolus in the stomach. The meal itself was richer in carbohydrate 
content (4.5%) and fat (2.9%) rather than protein (1.5%) and hence would be a good 
stimulus for GLP-1, PYY and CCK secretion by the enteroendocrine L cells and I cells 
respectively.  
The meal used for this experimental work was a homogenous soup rather than a solid 
meal. T1/2 for the gastric emptying was 57±5 min starting off with a maximal volume of 
458±20 ml. The gastric emptying was approximately linear from 0 min to 90 min post-
prandial. This finding is similar to our previous observations whereby following a solid 
meal with a drink, there is an initial rapid gastric emptying of the liquid drink in the first 
0 to 75 min postprandial, followed by slower phase of emptying of the solid food. The 
mean reported fullness VAS increased from 9.0 in the fasting state to 44 immediately 
postprandial with a decline to baseline within ~ 180 min. This rapid gastric emptying 
had an effect on the GI peptide responses to the test meal, changes in small bowel 
water content and the small bowel motility. In this work we once again observed a 
bimodal peak in small bowel water content in the postprandial state up to 270 min. The 
subjects’ mean fasting baseline small bowel water content was 39±2 ml, increasing to 
a maximum of 51±2ml. The volume decreased towards baseline (38±2ml) at 60 min in 
an early ‘gastric phase’ after which a second peak at 180 min was clearly seen with a 
volume of 65±3ml, otherwise known as a later ‘intestinal phase’29. The early drop 
observed is probably representative of absorption of water and available nutrients 
(sucrose and glucose) which are co-transported with sodium and water following the 
resulting osmotic gradient across the intestinal mucosa. This net absorption together 
with an activated post-prandial gastro-ileal reflex causing emptying of the contents of 
the distal ileum into the ascending colon, lead to a decrease in small bowel water 
   
content. The second peak or intestinal phase is due to an increase in pancreatico-
biliary and enterocyte secretion 31.  
The plasma levels of GLP-1 increased rapidly from 15±3 ug/ml to 22±4 ug/ml in 
response to the carbohydrate load within the meal.  It is known that one of the principal 
factors governing gastric emptying is the total carbohydrate load32, which through 
proximal duodenal absorption of simple digestible carbohydrates leads to an increase 
in GLP-1 secretion and a delay in gastric emptying10. The level of CCK usually 
increases 10-30 minutes after food intake8 as was confirmed in this study. In a parallel, 
gall bladder contraction occurred within 20 min of meal ingestion which would explain 
the 50% decrease in gall bladder volume.   
In this work we measured motility of the unprepared small bowel in response to a 
nutrient test meal for the first time. Mean motility peaked at 87±7 a.u. immediately 
postprandial. The early increase may be due to the fact that large boluses of meal 
move rapidly through the duodenum and upper jejunum increasing the volume amount 
of small bowel associated with the motion per unit of intestinal fluid volume present. 
Moreover, a prompt gastro-ileal reflex would facilitate emptying of the distal small 
bowel content into the ascending colon. The small bowel motility decreased back to 
baseline at approximately 90 minutes, when the emptying of the stomach has almost 
completed. This decrease coincided with maximal plasma levels of GLP-1 and PYY33, 
which have previously been associated with delayed small bowel transit34. Mean small 
bowel motility once again peaked at 120 min. There could be multiple possible 
explanations for this change. Between 90 and 120 min, mean plasma levels of PYY 
and GLP-1 dropped back to pre-prandial levels hence minimising their negative effect 
on small bowel motility. At a similar time period small bowel water content increased 
due to an increased in intestinal and pancreatico-biliary secretions. Such a small bowel 
   
distention could make small bowel motility more apparent and easier to measure or 
otherwise be a stimulus itself for smooth muscle contraction35. To our knowledge, this 
is the first time that such detailed and non-invasive assessment of small bowel 
physiology has ever been described in the post-prandial state with MRI.  
The whole gut transit time reported in this study was a median of 33 hours. This is 
comparable to our previous reports of 31 hours using the same methodology19.  
There are limitations in the study. The meal used was small in both volume and caloric 
intake, hence providing a submaximal stimulus to the GI tract. We chose this meal, 
due to its known effects on GI peptide response and because it could be tolerated in 
an otherwise sick patient population and could be administered safely and in a timely 
fashion in a clinical setting. Despite this postprandial physiological changes have been 
observed both in MR measures, patient symptoms and GI peptides. The age range 19-
50 years was broad though we would not expect major differences in GI motility within 
this range. 
In this study we have established an unprecedented platform for measuring post-
prandial small bowel motility in human subjects using MRI, and correlated this to known 
physiological GI peptide responses and symptoms. This work shows that such 
methodology exists and feasible. The length of our study is such that it may be difficult 
to implement in a busy clinical setting as is, though one could choose to scan only 
during the early postprandial time where the response is maximal. Presently intestinal 
motility had only been measured in the fasting state or on a bowel prepared with large 
volumes of luminal contrast, which may be less relevant to some of the post prandial 
symptoms experienced by patients. Mapping out such post-prandial physiological 
changes in disease groups will allow us to understand patient symptoms better and 
perhaps identify GI peptides as possible biomarkers of dysmotility and patient 
   
symptoms attributing to a poor quality of life. Further future work may be able to 
normalise such dysmotility through commercially available GI peptide inhibitors  
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Tables 
Table 1 
Visual analogue scale (100 mm VAS scores) 
Time 
point 
Fullness Bloating Distention Pain/discomfort Nausea/sickness 
-20 9±5 7±3 4±2 1±1 6±4 
0 44±5** 9±3 4±2 0±0 2±2 
15 41±6* 10±3 5±3 0±0 2±2 
30 41±6** 6±3 3±2 0±0 1±1 
45 37±7 7±3 3±2 0±0 1±1 
60 31±7 5±3 2±2 0±0 1±1 
90 26±6 5±3 3±3 0±0 0±0 
120 20±6 7±4 3±2 0±0 1±1 
150 13±4 4±2 1±1 0±0 0±0 
180 12±5 2±1 1±1 0±0 0±0 
210 7±4 1±1 1±1 0±0 0±0 
240 5±2 0±0 1±1 0±0 0±0 
270 3±1 0±0 0±0 0±0 0±0 
** p≤0.001 and *p<0.05 versus baseline value 
 
Table Captions 
Table 1: Visual analogue scale (100 mm VAS scores). 
 
  
   
Figure Captions 
 
Figure 1: Motility assessment. Reference image (A) and a motility map (B) for a healthy 
volunteer. ROI’s were placed on the reference image to include small bowel loops only.  
Figure 2: Changes in stomach content volumes. Data are mean ± SEM from n=15 
healthy volunteers. **** p≤0.0001 and *p<0.05 
Figure 3: Changes in small bowel motility. Data are mean ± SEM from n=15 healthy 
volunteers. *** p≤0.00, ** p≤0.001 and *p<0.05 
Figure 4: Changes in small bowel water contents. Data are mean ± SEM from n=15 
healthy volunteers. 
Figure 5: Changes in GLP-1 levels with study time. Data are mean ± SEM from n=15 
healthy volunteers.  
Figure 6: Changes in PYY levels with study time. Data are mean ± SEM from n=15 
healthy volunteers. *** p≤0.00, ** p≤0.001 and *p<0.05 
Figure 7: Changes in CCK plasma levels with study time. Data are mean ± SEM from 
n=15 healthy volunteers. ** p≤0.001 and *p<0.05 
 
Supporting information 
Figure S1: Diagram summarizing the study protocol. 
Figure S2: Changes in gallbladder volume. Data are mean ± SEM from n=15 healthy 
volunteers. **** p≤0.0001 
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